Genetic Analysis of the Chiari I Malformation
Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Feb 26, 2000
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Objectives: The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa.
Study Population: Patients and family members of patients with the Chiari I malformation. Because the research institutions are located in the United States and Russia, subjects will be recruited predominantly from these countries.
Design: Human subjects will undergo 1) neurologic examinations, 2) head and cervical MRI scans to evaluate for the ...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- To be eligible for entry into the study, a candidate must meet the following criteria:
- • Patient with a confirmed diagnosis of Chiari I malformation who has a family member with syringomyelia or Chiari I malformation, or
- • Family member of a patient with a confirmed diagnosis of Chiari I malformation, AND
- • There are at least two family members diagnosed with Chiari I malformation.
- • If an adult, able to give informed consent; if a minor, has an adult who is legally responsible for the subject and who is able to give consent.
- EXCLUSION CRITERIA:
- A candidate will be excluded if he/she:
- • Has a contraindication to MRI scanning.
- • Is unable to comprehend the risks of the testing.
- • Is less than one year of age.
- • Cannot undergo MRI scanning without sedation.
About National Institute Of Neurological Disorders And Stroke (Ninds)
The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Kazan, , Russian Federation
Patients applied
Trial Officials
John D Heiss, M.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials